In preclinical glioblastoma models, brain endothelial cell-derived EVs loaded with VEGF siRNA were able to reach intracranial tumors after systemic administration and inhibit tumor-induced angiogenesis [138]. The gene discussed is VEGFA; the disease is glioblastoma.